<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01079390</url>
  </required_header>
  <id_info>
    <org_study_id>2009-P-000904</org_study_id>
    <secondary_id>1R21AT004497-01A2</secondary_id>
    <nct_id>NCT01079390</nct_id>
  </id_info>
  <brief_title>An Acupuncture Functional Magnetic Resonance Imaging (fMRI) Study on Chronic Pain: Response Reliability and Dose Effect</brief_title>
  <official_title>An Acupuncture fMRI Study on Chronic Pain: Response Reliability and Dose Effect</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this proposal, we plan to dynamically investigate brain response to verum acupuncture (of
      two different &quot;doses&quot;) and placebo acupuncture, using a paradigm that approximates clinical
      acupuncture practice across multiple treatment sessions in knee osteoarthritis (OA) patients.
      This proposal aims to: 1) characterize session-to-session brain responses to verum / sham
      acupuncture treatment (reliability of response) for OA patients, and 2) investigate how
      different &quot;doses&quot; of acupuncture influence brain response and acupuncture efficacy (impact of
      dose). The findings of this project will deepen our biological understanding on why and how
      acupuncture can treat chronic pain and what happens in the brain during the multiple-session
      acupuncture treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee Injury and Osteoarthritis Outcome Score (KOOS Pain Rating) at 5-7 Weeks Post-Treatment</measure>
    <time_frame>One post-treatment measurement 5-7 weeks after baseline</time_frame>
    <description>The Knee injury and Osteoarthritis Outcome Score (KOOS) was used to measure clinical outcomes. KOOS is measured on a scale from 0-4 with 0 being no pain and 4 being extreme pain (the worst). The KOOS is comprised of 5 subscales, each of which produces an outcome score. These subscales include pain, other symptoms, function in daily living (ADL), function in sport and recreation, and knee-related quality of life (QOL). Based on previous studies, subscale scores of the KOOS related to pain, function in daily living, and function in sport and recreation were selected as the primary outcome of the present study. For each subscale, a normalized score was calculated, where 0 indicated the most extreme symptoms/pain and 100 indicated no symptoms/pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cortical Thickness Changes at 5-7 Weeks Post-Treatment</measure>
    <time_frame>2 days; one at baseline and another post-treatment measurement taken 5-7 weeks after baseline</time_frame>
    <description>All eligible patients were scanned using fMRI while receiving treatment during acupuncture sessions 1, 3, and 6. Structural MRI data were only compared between Session 1 (pre-treatment) and Session 6 (post-treatment). The structural data was analyzed using FreeSurfer software.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>High dose acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>six needle applied during acupuncture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>two needles will be applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo acupuncture</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>sham acupuncture treatment will be applied</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>acupuncture</intervention_name>
    <description>patient will receive high dose, low dose or sham acupuncture treatment.</description>
    <arm_group_label>High dose acupuncture</arm_group_label>
    <arm_group_label>Low dose acupuncture</arm_group_label>
    <arm_group_label>placebo acupuncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Volunteers 40-70 years of age.

          2. Meet the Classification Criteria of the American College of Rheumatology for
             osteoarthritis of the left / right knee for at least the past 3 months, as determined
             by the referring physician.

          3. Radiographic evidence of Grade 2 or 3 knee OA using the Kellgren-Lawrence Scale [78,
             85-87].

          4. Patients must have moderate or greater clinically significant pain on most days during
             the past month (more than 15 days out of 30, of average daily pain of &gt;3/10) in the
             left or right knee.

          5. At least a 10th grade English-reading level; English can be a second language provided
             that the patients feel they understand all the questions used in the assessment
             measures.

        Exclusion Criteria:

          1. Any interventional procedure for knee pain, including corticosteroid injections
             (within 6 months, [88]) to the knee.

          2. Prior acupuncture treatment for any condition. Because we are using a placebo needle
             as a control, acupuncture-naive patients are necessary to maximize the benefits of
             blinding and to control expectancy.

          3. The intent to undergo surgery during the time of involvement in the study.

          4. Presence of any illness or medication use that is judged to interfere with the trial.
             For example: skin irritations around the knee such as psoriasis; bleeding disorders or
             anticoagulant use that would be contraindications for acupuncture; opioids or
             benzodiazepines, which may alter pain sensitivity and BOLD response.

          5. Knee pain due to other causes, such as inflammation or malignancy, other pain
             disorders that may refer pain to the leg, OA of ipsilateral hip, diagnosis of RA.

          6. Non-ambulatory status.

          7. History of cardiac, respiratory, or nervous system disease that, in the investigator's
             judgment, precludes participation in the study because of a heightened potential for
             adverse outcome. For example: asthma or claustrophobia.

          8. Presence of any contraindications to fMRI scanning. For example: cardiac pacemaker,
             metal implants, fear of closed spaces, pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jian Kong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hosptial</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hosptial</name>
      <address>
        <city>Charlestown</city>
        <state>Massachusetts</state>
        <zip>02129</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2010</study_first_submitted>
  <study_first_submitted_qc>March 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2010</study_first_posted>
  <results_first_submitted>March 25, 2014</results_first_submitted>
  <results_first_submitted_qc>July 12, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 10, 2017</results_first_posted>
  <last_update_submitted>July 12, 2017</last_update_submitted>
  <last_update_submitted_qc>July 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Jian Kong</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <keyword>osteoarthritis</keyword>
  <keyword>fMRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Forty-four acupuncture naïve patients aged 43-70 with a diagnosis of chronic osteoarthritis in the right and/or left knee participated in the study. 30 (13 females) completed all study procedures. Fourteen subjects did not complete the study. All subjects were recruited form the Boston area over the course of the past 3 years.</recruitment_details>
      <pre_assignment_details>Fourteen subjects did not complete the study due to problems with scheduling (6), ineligibility at screening (3), disinterest (2), claustrophobia (1), or inability to adhere to study requirements in scanner (2). Of the 14 subjects who dropped, four dropped out after randomization.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>High Dose Acupuncture</title>
          <description>six needle applied during acupuncture
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
        </group>
        <group group_id="P2">
          <title>Low Dose Acupuncture</title>
          <description>two needles will be applied.
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
        </group>
        <group group_id="P3">
          <title>Placebo Acupuncture</title>
          <description>sham acupuncture treatment will be applied
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>High Dose Acupuncture</title>
          <description>six needle applied during acupuncture
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
        </group>
        <group group_id="B2">
          <title>Low Dose Acupuncture</title>
          <description>two needles will be applied.
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
        </group>
        <group group_id="B3">
          <title>Placebo Acupuncture</title>
          <description>sham acupuncture treatment will be applied
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="14"/>
            <count group_id="B4" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60" spread="9"/>
                    <measurement group_id="B2" value="58" spread="8"/>
                    <measurement group_id="B3" value="54" spread="7"/>
                    <measurement group_id="B4" value="58" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Knee Injury and Osteoarthritis Outcome Score (KOOS Pain Rating) at 5-7 Weeks Post-Treatment</title>
        <description>The Knee injury and Osteoarthritis Outcome Score (KOOS) was used to measure clinical outcomes. KOOS is measured on a scale from 0-4 with 0 being no pain and 4 being extreme pain (the worst). The KOOS is comprised of 5 subscales, each of which produces an outcome score. These subscales include pain, other symptoms, function in daily living (ADL), function in sport and recreation, and knee-related quality of life (QOL). Based on previous studies, subscale scores of the KOOS related to pain, function in daily living, and function in sport and recreation were selected as the primary outcome of the present study. For each subscale, a normalized score was calculated, where 0 indicated the most extreme symptoms/pain and 100 indicated no symptoms/pain.</description>
        <time_frame>One post-treatment measurement 5-7 weeks after baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High Dose Acupuncture</title>
            <description>six needle applied during acupuncture
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
          </group>
          <group group_id="O2">
            <title>Low Dose Acupuncture</title>
            <description>two needles will be applied.
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
          </group>
          <group group_id="O3">
            <title>Placebo Acupuncture</title>
            <description>sham acupuncture treatment will be applied
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Knee Injury and Osteoarthritis Outcome Score (KOOS Pain Rating) at 5-7 Weeks Post-Treatment</title>
          <description>The Knee injury and Osteoarthritis Outcome Score (KOOS) was used to measure clinical outcomes. KOOS is measured on a scale from 0-4 with 0 being no pain and 4 being extreme pain (the worst). The KOOS is comprised of 5 subscales, each of which produces an outcome score. These subscales include pain, other symptoms, function in daily living (ADL), function in sport and recreation, and knee-related quality of life (QOL). Based on previous studies, subscale scores of the KOOS related to pain, function in daily living, and function in sport and recreation were selected as the primary outcome of the present study. For each subscale, a normalized score was calculated, where 0 indicated the most extreme symptoms/pain and 100 indicated no symptoms/pain.</description>
          <units>units on KOOS scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59" spread="13"/>
                    <measurement group_id="O2" value="53" spread="9"/>
                    <measurement group_id="O3" value="56" spread="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cortical Thickness Changes at 5-7 Weeks Post-Treatment</title>
        <description>All eligible patients were scanned using fMRI while receiving treatment during acupuncture sessions 1, 3, and 6. Structural MRI data were only compared between Session 1 (pre-treatment) and Session 6 (post-treatment). The structural data was analyzed using FreeSurfer software.</description>
        <time_frame>2 days; one at baseline and another post-treatment measurement taken 5-7 weeks after baseline</time_frame>
        <population>We combined low and high dose acupuncture into one group because we found there were not clinical differences between the two group.</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>six needle applied during acupuncture
acupuncture : patient will receive high or low dose.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Acupuncture</title>
            <description>sham acupuncture treatment will be applied
acupuncture : patient will receive sham acupuncture treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Cortical Thickness Changes at 5-7 Weeks Post-Treatment</title>
          <description>All eligible patients were scanned using fMRI while receiving treatment during acupuncture sessions 1, 3, and 6. Structural MRI data were only compared between Session 1 (pre-treatment) and Session 6 (post-treatment). The structural data was analyzed using FreeSurfer software.</description>
          <population>We combined low and high dose acupuncture into one group because we found there were not clinical differences between the two group.</population>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="0.15"/>
                    <measurement group_id="O2" value="3.13" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>High Dose Acupuncture</title>
          <description>six needle applied during acupuncture
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
        </group>
        <group group_id="E2">
          <title>Low Dose Acupuncture</title>
          <description>two needles will be applied.
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
        </group>
        <group group_id="E3">
          <title>Placebo Acupuncture</title>
          <description>sham acupuncture treatment will be applied
acupuncture : patient will receive high dose, low dose or sham acupuncture treatment.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limitations of the study are the small sample size as well as the effects of factors such as age, gender, and chronic duration of pain.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Jian Kong</name_or_title>
      <organization>Mass General Hospital</organization>
      <phone>617-726-7893</phone>
      <email>kongj@nmr.mgh.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

